Regulation of vulnerable plaque development by the heme oxygenase/carbon monoxide system

Trends in Cardiovascular Medicine

Volumn 20, Issue 2, 2010, Pages 58-65

  Larsen, Katarína ^a   Cheng, Caroline ^a   Duckers, Henricus J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; HEART PROTECTION; HUMAN; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOGENESIS; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; CARBON MONOXIDE; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; HEME OXYGENASE (DECYCLIZING); HUMANS; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC; RATS;

EID: 77955072380     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.04.001     Document Type: Review

References (83)

1. Amit Y., Boneh A. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta 1993, 223:103-111.
2. Arbustini E., Dal Bello B., Morbini P., et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999, 82:269-272.
3. Balla G., Jacob H.S., Balla J., et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992, 267:18148-18153.
4. Balla J., Vercellotti G.M., Jeney V., et al. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 2007, 9:2119-2137.
5. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
6. Bouche D., Chauveau C., Roussel J.C., et al. Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer. Transpl Immunol 2002, 9:235-238.
7. Brouard S., Otterbein L.E., Anrather J., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000, 192:1015-1026.
8. Brune B., Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987, 32:497-504.
9. Burke A.P., Farb A., Malcom G.T., et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998, 97:2110-2116.
10. Burke A.P., Farb A., Malcom G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
11. Bussolati B., Ahmed A., Pemberton H., et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004, 103:761-766.
12. Celletti F.L., Waugh J.M., Amabile P.G., et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001, 7:425-429.
13. Chen S.M., Li Y.G., Wang D.M. Study on changes of heme oxygenase 1 expression in patients with coronary heart disease. Clin Cardiol 2005, 28:197-201.
14. Cheng C., Noordeloos A.M., Jeney V., et al. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 2009, 119:3017-3027.
15. Clark J.E., Foresti R., Sarathchandra P., et al. Heme oxygenase 1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000, 278:H643-651.
16. Di Stefano R., Felice F., Balbarini A. Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 2009, 15:1095-1106.
17. Doi K., Akaike T., Fujii S., et al. Induction of heme oxygenase 1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 1999, 80:1945-1954.
18. Duckers H.J., Boehm M., True A.L., et al. Heme oxygenase 1 protects against vascular constriction and proliferation. Nat Med 2001, 7:693-698.
19. Fujita T., Toda K., Karimova A., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 2001, 7:598-604.
20. Gerard C., Bruyns C., Marchant A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993, 177:547-550.
21. Hansen T.W., Mathiesen S.B., Walaas S.I. Bilirubin has widespread inhibitory effects on protein phosphorylation. Pediatr Res 1996, 39:1072-1077.
22. Hopkins P.N., Wu L.L., Hunt S.C., et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996, 16:250-255.
23. Idriss N.K., Blann A.D., Lip G.Y. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008, 52:971-978.
24. Ishikawa K., Sugawara D., Goto J., et al. Heme oxygenase 1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001, 104:1831-1836.
25. Jonasson L., Holm J., Skalli O., et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
26. Jozkowicz A., Huk I., Nigisch A., et al. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 2003, 5:155-162.
27. Kapitulnik J., Maines M.D. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol Sci 2009, 30:129-137.
28. Kawamura K., Ishikawa K., Wada Y., et al. Bilirubin from heme oxygenase 1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 2005, 25:155-160.
29. Kim H.P., Wang X., Zhang J., et al. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: involvement of p38 beta MAPK and heat shock factor-1. J Immunol 2005, 175:2622-2629.
30. Kwak J.Y., Takeshige K., Cheung B.S., Minakami S. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim Biophys Acta 1991, 1076:369-373.
31. Lavrovsky Y., Schwartzman M.L., Levere R.D., et al. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 1994, 91:5987-5991.
32. Lee H.S., Chang J.S., Baek J.A., et al. TNF-alpha activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochem Biophys Res Commun 2005, 333:1093-1099.
33. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8:240-246.
34. Li Y.G., Wang D.M., Chen S.M., et al. Haem oxygenase 1 expression and coronary heart disease-association between levels of haem oxygenase 1 expression and angiographic morphology as well as the quantity of coronary lesions. Acta Cardiol 2006, 61:295-300.
35. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
36. Libby P., Ordovas J.M., Auger K.R., et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986, 124:179-185.
37. Liu X.M., Chapman G.B., Peyton K.J., et al. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 2002, 55:396-405.
38. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000, 46:1723-1727.
39. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:1786-1795.
40. Morita T., Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995, 96:2676-2682.
41. Morsi W.G., Shaker O.G., Ismail E.F., et al. HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 2006, 39:1057-1062.
42. Motterlini R., Clark J.E., Foresti R., et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002, 90:E17-24.
43. Motterlini R., Gonzales A., Foresti R., et al. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998, 83:568-577.
44. Moulton K.S., Heller E., Konerding M.A., et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99:1726-1732.
45. Moulton K.S., Vakili K., Zurakowski D., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003, 100:4736-4741.
46. Nakao A., Neto J.S., Kanno S., et al. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005, 5:282-291.
47. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994, 269:16712-16719.
48. O'Brien K.D., McDonald T.O., Chait A., et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996, 93:672-682.
49. Obara H., Takayanagi A., Hirahashi J., et al. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000, 20:2198-2204.
50. Ollinger R., Bilban M., Erat A., et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005, 112:1030-1039.
51. Otterbein L.E., Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1029-1037.
52. Otterbein L.E., Mantell L.L., Choi A.M. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999, 276:L688-L694.
53. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24:449-455.
54. Otterbein L.E., Zuckerbraun B.S., Haga M., et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003, 9:183-190.
55. Petrache I., Otterbein L.E., Alam J., et al. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 2000, 278:L312-L319.
56. Pinderski L.J., Fischbein M.P., Subbanagounder G., et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002, 90:1064-1071.
57. Reeve V.E., Tyrrell R.M. Heme oxygenase induction mediates the photoimmunoprotective activity of UVA radiation in the mouse. Proc Natl Acad Sci U S A 1999, 96:9317-9321.
58. Rho M.C., Kim Y.K., Chang J.S., et al. 7-Ketocholesterol predisposes human aorta smooth muscle cells to Fas-mediated death. J Mol Cell Cardiol 2005, 39:823-832.
59. Rizzardini M., Terao M., Falciani F., Cantoni L. Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J 1993, 290(Pt 2):343-347.
60. Rodriguez A.I., Gangopadhyay A., Kelley E.E., et al. HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1. Arterioscler Thromb Vasc Biol 2010, 30:98-104.
61. Ross R., Masuda J., Raines E.W., et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990, 248:1009-1012.
62. Rushworth S.A., MacEwan D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 2008, 111:3793-3801.
63. Sarady J.K., Otterbein S.L., Liu F., et al. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 2002, 27:739-745.
64. Sato K., Balla J., Otterbein L., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001, 166:4185-4194.
65. Schaar J.A., Muller J.E., Falk E., et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004, 25:1077-1082.
66. Schwertner H.A., Jackson W.G., Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994, 40:18-23.
67. Shimomura H., Ogawa H., Takazoe K., et al. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol 2002, 90:108-111.
68. Silva G., Cunha A., Gregoire I.P., et al. The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. J Immunol 2006, 177:1894-1903.
69. Soares M.P., Bach F.H. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med 2009, 15:50-58.
70. Soares M.P., Lin Y., Anrather J., et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998, 4:1073-1077.
71. Soares M.P., Lin Y., Sato K., et al. Accommodation. Immunol Today 1999, 20:434-437.
72. Stocker R., Yamamoto Y., McDonagh A.F., et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
73. Tabas I., Seimon T., Timmins J., et al. Macrophage apoptosis in advanced atherosclerosis. Ann N Y Acad Sci 2009, 1173(Suppl 1):E40-45.
74. Testa U., Pannitteri G., Condorelli G.L. Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown) 2008, 9:1190-1221.
75. Tomaro M.L., Batlle A.M. Bilirubin: its role in cytoprotection against oxidative stress. Int J Biochem Cell Biol 2002, 34:216-220.
76. Vile G.F., Basu-Modak S., Waltner C., Tyrrell R.M. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A 1994, 91:2607-2610.
77. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47:C13-18.
78. Virmani R., Kolodgie F.D., Burke A.P., et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
79. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 1996, 2:87-90.
80. Yachie A., Niida Y., Wada T., et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103:129-135.
81. Yet S.F., Layne M.D., Liu X., et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. Faseb J 2003, 17:1759-1761.
82. Yet S.F., Perrella M.A., Layne M.D., et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999, 103:R23-29.
83. Zhen-Wei X., Jian-Le S., Qi Q., et al. Heme oxygenase-1 improves the survival of discordant cardiac xenograft through its anti-inflammatory and anti-apoptotic effects. Pediatr Transplant 2007, 11:850-859.